GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings

GoodRx Holdings Inc GDRX got an upgrade last month from Wells Fargo analyst.

Despite being a “re-accelerating high-growth, high-margin company,” the stock was trading at a discount both to its peers and its historical average, according to KeyBanc Capital Markets.

The GoodRx Holdings Club Analyst: Scott Schoenhaus upgraded the rating for GoodRx Holdings to Overweight while revising the price target to $9.

The GoodRx Holdings Club Thesis: Signs of the company’s app downloads have been “encouraging,” having accelerated in February and remaining stable in March, despite tougher comps, Schoenhaus said in the upgrade note.

Check out other analyst stock ratings.

Monthly active users (MAUs) climbed around 8.7% sequentially in February and about 2.4% in March, “which we view as a positive indication on transactions,” the analyst wrote.

According to the data from the proprietary KeyBank card holders, Gold subscribers picked up around 2% sequentially in March, Schoenhaus stated. “This is prior to the new Publix addition, where Gold membership is being rolled out across more than 1,200 locations,” he added.

GDRX Price Action: Shares of GoodRx Holdings had risen by 2.08% to $6.88 at the time of publication on Wednesday.

Read Next: Inflation Rises More Than Expected To 3.5% In March, Derails June Rate Cut Hopes (UPDATED)

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: Analyst ColorEarningsLong IdeasNewsUpgradesHealth CarePrice TargetAnalyst RatingsMoversTrading IdeasGeneralExpert IdeasKeyBanc Capital MarketspharmaceuticalspharmacyScott SchoenhausStories That Matter
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!